Qvanteq AG

The core activity of Qvanteq AG is the development of biofunctional surfaces for medical devices and vascular stents, particularly with the goal of reducing thrombogenic effects and accelerating healing. The company focuses on developing technologies that prevent the activation of the blood coagulation cascade, thereby minimizing complications from medical devices and stents.